Does the media prefer HAE or KMTS?

In the previous week, Kestra Medical Technologies had 26 more articles in the media than Haemonetics. MarketBeat recorded 29 mentions for Kestra Medical Technologies and 3 mentions for Haemonetics. Haemonetics' average media sentiment score of 1.02 beat Kestra Medical Technologies' score of 0.08 indicating that Haemonetics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Kestra Medical Technologies 6 Very Positive mention(s) 5 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to KMTS or LIVN?

In the previous week, Kestra Medical Technologies had 16 more articles in the media than LivaNova. MarketBeat recorded 29 mentions for Kestra Medical Technologies and 13 mentions for LivaNova. LivaNova's average media sentiment score of 0.68 beat Kestra Medical Technologies' score of 0.08 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 6 Very Positive mention(s) 5 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral LivaNova 6 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer KMTS or ITGR?

In the previous week, Kestra Medical Technologies had 20 more articles in the media than Integer. MarketBeat recorded 29 mentions for Kestra Medical Technologies and 9 mentions for Integer. Integer's average media sentiment score of 0.44 beat Kestra Medical Technologies' score of 0.08 indicating that Integer is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 6 Very Positive mention(s) 5 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral Integer 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to IRTC or KMTS?

In the previous week, Kestra Medical Technologies had 25 more articles in the media than iRhythm Technologies. MarketBeat recorded 29 mentions for Kestra Medical Technologies and 4 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.65 beat Kestra Medical Technologies' score of 0.08 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Kestra Medical Technologies 6 Very Positive mention(s) 5 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to KMTS or PLSE?

In the previous week, Kestra Medical Technologies had 18 more articles in the media than Pulse Biosciences. MarketBeat recorded 29 mentions for Kestra Medical Technologies and 11 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.97 beat Kestra Medical Technologies' score of 0.08 indicating that Pulse Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 6 Very Positive mention(s) 5 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral Pulse Biosciences 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Kestra Medical Technologies (KMTS) Competitors

$24.18 +0.12 (+0.50%)

As of 10:44 AM Eastern

Compare

KMTS vs. HAE, LIVN, ITGR, IRTC, and PLSE

Should you buy Kestra Medical Technologies stock or one of its competitors? Kestra Medical Technologies's main competitors and comparable companies include Haemonetics (HAE), LivaNova (LIVN), Integer (ITGR), iRhythm Technologies (IRTC), and Pulse Biosciences (PLSE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Kestra Medical Technologies compare to Haemonetics?

Haemonetics (NYSE:HAE) and Kestra Medical Technologies (NASDAQ:KMTS) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, media sentiment, risk, institutional ownership, earnings and analyst recommendations.

99.7% of Haemonetics shares are owned by institutional investors. 2.1% of Haemonetics shares are owned by company insiders. Comparatively, 5.3% of Kestra Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Haemonetics currently has a consensus target price of $99.78, suggesting a potential downside of 4.80%. Kestra Medical Technologies has a consensus target price of $28.14, suggesting a potential upside of 16.39%. Given Kestra Medical Technologies' higher possible upside, analysts clearly believe Kestra Medical Technologies is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

In the previous week, Kestra Medical Technologies had 26 more articles in the media than Haemonetics. MarketBeat recorded 29 mentions for Kestra Medical Technologies and 3 mentions for Haemonetics. Haemonetics' average media sentiment score of 1.02 beat Kestra Medical Technologies' score of 0.08 indicating that Haemonetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Kestra Medical Technologies	6 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral

Haemonetics has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market.

Haemonetics has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.35B	3.53	$97.31M	$2.04	51.38
Kestra Medical Technologies	$95.13M	14.90	-$131.61M	-$2.42	N/A

Haemonetics has a net margin of 7.12% compared to Kestra Medical Technologies' net margin of -138.35%. Haemonetics' return on equity of 27.55% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	7.12%	27.55%	9.65%
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%

Summary

Haemonetics beats Kestra Medical Technologies on 12 of the 17 factors compared between the two stocks.

How does Kestra Medical Technologies compare to LivaNova?

Kestra Medical Technologies (NASDAQ:KMTS) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.

Kestra Medical Technologies presently has a consensus price target of $28.14, indicating a potential upside of 16.39%. LivaNova has a consensus price target of $84.13, indicating a potential upside of 5.74%. Given Kestra Medical Technologies' higher probable upside, equities research analysts plainly believe Kestra Medical Technologies is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
LivaNova	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.55

Kestra Medical Technologies has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

Kestra Medical Technologies has higher earnings, but lower revenue than LivaNova. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$95.13M	14.90	-$131.61M	-$2.42	N/A
LivaNova	$1.39B	3.16	-$242.47M	$3.38	23.54

LivaNova has a net margin of 12.82% compared to Kestra Medical Technologies' net margin of -138.35%. LivaNova's return on equity of 16.35% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%
LivaNova	12.82%	16.35%	7.76%

In the previous week, Kestra Medical Technologies had 16 more articles in the media than LivaNova. MarketBeat recorded 29 mentions for Kestra Medical Technologies and 13 mentions for LivaNova. LivaNova's average media sentiment score of 0.68 beat Kestra Medical Technologies' score of 0.08 indicating that LivaNova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kestra Medical Technologies	6 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral
LivaNova	6 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

97.6% of LivaNova shares are owned by institutional investors. 5.3% of Kestra Medical Technologies shares are owned by company insiders. Comparatively, 0.4% of LivaNova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

LivaNova beats Kestra Medical Technologies on 11 of the 16 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Integer?

Kestra Medical Technologies (NASDAQ:KMTS) and Integer (NYSE:ITGR) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership.

Integer has a net margin of 6.97% compared to Kestra Medical Technologies' net margin of -138.35%. Integer's return on equity of 12.79% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%
Integer	6.97%	12.79%	6.48%

Kestra Medical Technologies currently has a consensus price target of $28.14, indicating a potential upside of 16.39%. Integer has a consensus price target of $109.86, indicating a potential downside of 12.97%. Given Kestra Medical Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe Kestra Medical Technologies is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

99.3% of Integer shares are owned by institutional investors. 5.3% of Kestra Medical Technologies shares are owned by insiders. Comparatively, 1.1% of Integer shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Integer has higher revenue and earnings than Kestra Medical Technologies. Kestra Medical Technologies is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$95.13M	14.90	-$131.61M	-$2.42	N/A
Integer	$1.85B	2.31	$102.81M	$3.66	34.49

In the previous week, Kestra Medical Technologies had 20 more articles in the media than Integer. MarketBeat recorded 29 mentions for Kestra Medical Technologies and 9 mentions for Integer. Integer's average media sentiment score of 0.44 beat Kestra Medical Technologies' score of 0.08 indicating that Integer is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kestra Medical Technologies	6 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral
Integer	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Kestra Medical Technologies has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market. Comparatively, Integer has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market.

Summary

Integer beats Kestra Medical Technologies on 9 of the 15 factors compared between the two stocks.

How does Kestra Medical Technologies compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Kestra Medical Technologies (NASDAQ:KMTS) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

iRhythm Technologies has a net margin of -1.69% compared to Kestra Medical Technologies' net margin of -138.35%. iRhythm Technologies' return on equity of 10.11% beat Kestra Medical Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-1.69%	10.11%	1.53%
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%

In the previous week, Kestra Medical Technologies had 25 more articles in the media than iRhythm Technologies. MarketBeat recorded 29 mentions for Kestra Medical Technologies and 4 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.65 beat Kestra Medical Technologies' score of 0.08 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Kestra Medical Technologies	6 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral

iRhythm Technologies has higher revenue and earnings than Kestra Medical Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Kestra Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.92	-$44.55M	-$0.43	N/A
Kestra Medical Technologies	$95.13M	14.90	-$131.61M	-$2.42	N/A

iRhythm Technologies presently has a consensus target price of $179.93, indicating a potential upside of 61.44%. Kestra Medical Technologies has a consensus target price of $28.14, indicating a potential upside of 16.39%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, equities analysts plainly believe iRhythm Technologies is more favorable than Kestra Medical Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

iRhythm Technologies has a beta of 1.31, suggesting that its stock price is 31% more volatile than the broader market. Comparatively, Kestra Medical Technologies has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market.

Summary

iRhythm Technologies beats Kestra Medical Technologies on 12 of the 15 factors compared between the two stocks.

How does Kestra Medical Technologies compare to Pulse Biosciences?

Kestra Medical Technologies (NASDAQ:KMTS) and Pulse Biosciences (NASDAQ:PLSE) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

Kestra Medical Technologies presently has a consensus price target of $28.14, suggesting a potential upside of 16.39%. Pulse Biosciences has a consensus price target of $45.25, suggesting a potential downside of 15.96%. Given Kestra Medical Technologies' higher possible upside, analysts clearly believe Kestra Medical Technologies is more favorable than Pulse Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kestra Medical Technologies	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Pulse Biosciences	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83

In the previous week, Kestra Medical Technologies had 18 more articles in the media than Pulse Biosciences. MarketBeat recorded 29 mentions for Kestra Medical Technologies and 11 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.97 beat Kestra Medical Technologies' score of 0.08 indicating that Pulse Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kestra Medical Technologies	6 Very Positive mention(s)	5 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral
Pulse Biosciences	4 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Pulse Biosciences has lower revenue, but higher earnings than Kestra Medical Technologies. Pulse Biosciences is trading at a lower price-to-earnings ratio than Kestra Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kestra Medical Technologies	$95.13M	14.90	-$131.61M	-$2.42	N/A
Pulse Biosciences	$350K	10,647.46	-$72.78M	-$1.18	N/A

Kestra Medical Technologies has a net margin of -138.35% compared to Pulse Biosciences' net margin of -6,755.78%. Kestra Medical Technologies' return on equity of -57.38% beat Pulse Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kestra Medical Technologies	-138.35%	-57.38%	-41.10%
Pulse Biosciences	-6,755.78%	-94.42%	-79.96%

Kestra Medical Technologies has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market. Comparatively, Pulse Biosciences has a beta of 1.63, indicating that its share price is 63% more volatile than the broader market.

77.0% of Pulse Biosciences shares are held by institutional investors. 5.3% of Kestra Medical Technologies shares are held by company insiders. Comparatively, 74.0% of Pulse Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Pulse Biosciences beats Kestra Medical Technologies on 9 of the 16 factors compared between the two stocks.

Get Kestra Medical Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KMTS vs. The Competition

Export

Metric	Kestra Medical Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.42B	$5.39B	$7.15B	$14.21B
Dividend Yield	N/A	1.80%	2.57%	11.71%
P/E Ratio	-9.99	24.87	273.46	25.34
Price / Sales	14.90	83.09	670.93	98.74
Price / Cash	N/A	33.03	28.42	34.96
Price / Book	5.43	5.99	10.43	6.20
Net Income	-$131.61M	$149.33M	$3.48B	$357.95M
7 Day Performance	-5.69%	-1.81%	-1.90%	-1.21%
1 Month Performance	-13.70%	-3.67%	-0.14%	-3.22%
1 Year Performance	6.61%	9.21%	19.12%	6.27%

Kestra Medical Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KMTS Kestra Medical Technologies	1.7749 of 5 stars	$24.18 +0.5%	$28.14 +16.4%	+10.2%	$1.42B	$95.13M	N/A	443	Trending News Earnings Report Analyst Downgrade
HAE Haemonetics	2.0121 of 5 stars	$103.00 +0.1%	$99.78 -3.1%	+103.3%	$4.68B	$1.33B	50.49	3,009	Positive News
LIVN LivaNova	2.3983 of 5 stars	$81.92 +0.9%	$84.13 +2.7%	+43.4%	$4.47B	$1.47B	24.24	3,300	News Coverage Insider Trade
ITGR Integer	2.5613 of 5 stars	$126.40 +0.7%	$109.86 -13.1%	+24.3%	$4.27B	$1.85B	34.54	11,000
IRTC iRhythm Technologies	3.9182 of 5 stars	$123.07 -0.3%	$179.93 +46.2%	-36.2%	$4.07B	$825.34M	N/A	2,400	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KMTS) was last updated on 9/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kestra Medical Technologies (KMTS) Competitors

KMTS vs. HAE, LIVN, ITGR, IRTC, and PLSE

How does Kestra Medical Technologies compare to Haemonetics?

Summary

How does Kestra Medical Technologies compare to LivaNova?

Summary

How does Kestra Medical Technologies compare to Integer?

Summary

How does Kestra Medical Technologies compare to iRhythm Technologies?

Summary

How does Kestra Medical Technologies compare to Pulse Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KMTS vs. The Competition

Kestra Medical Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kestra Medical Technologies (KMTS) Competitors

KMTS vs. HAE, LIVN, ITGR, IRTC, and PLSE

How does Kestra Medical Technologies compare to Haemonetics?

Do institutionals and insiders have more ownership in HAE or KMTS?

Do analysts rate HAE or KMTS?

Does the media prefer HAE or KMTS?

Which has more volatility & risk, HAE or KMTS?

Which has better earnings and valuation, HAE or KMTS?

Is HAE or KMTS more profitable?

Summary

How does Kestra Medical Technologies compare to LivaNova?

Do analysts prefer KMTS or LIVN?

Which has more volatility & risk, KMTS or LIVN?

Which has preferable earnings & valuation, KMTS or LIVN?

Is KMTS or LIVN more profitable?

Does the media refer more to KMTS or LIVN?

Do institutionals & insiders believe in KMTS or LIVN?

Summary

How does Kestra Medical Technologies compare to Integer?

Is KMTS or ITGR more profitable?

Do analysts rate KMTS or ITGR?

Do insiders & institutionals have more ownership in KMTS or ITGR?

Which has stronger earnings and valuation, KMTS or ITGR?

Does the media prefer KMTS or ITGR?

Which has more risk & volatility, KMTS or ITGR?

Summary

How does Kestra Medical Technologies compare to iRhythm Technologies?

Is IRTC or KMTS more profitable?

Does the media refer more to IRTC or KMTS?

Which has stronger valuation and earnings, IRTC or KMTS?

Do analysts rate IRTC or KMTS?

Which has more volatility & risk, IRTC or KMTS?

Summary

How does Kestra Medical Technologies compare to Pulse Biosciences?

Do analysts prefer KMTS or PLSE?

Does the media refer more to KMTS or PLSE?

Which has stronger valuation & earnings, KMTS or PLSE?

Is KMTS or PLSE more profitable?

Which has more volatility and risk, KMTS or PLSE?

Do institutionals & insiders hold more shares of KMTS or PLSE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KMTS vs. The Competition

Kestra Medical Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools